ArticleACS omega2026
Berberine-Loaded Mesoporous Bioactive Glass Enhances Bone Repair through Combined Immunomodulatory and Osteogenic Effects.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone repair is dependent on both local inflammatory control and osteogenic activity. In this study, berberine-loaded mesoporous bioactive glass (BG) nanoparticles (BG@Ber) were prepared to combine the osteogenic properties of mesoporous BG with the anti-inflammatory activity of berberine. The results showed that berberine was successfully loaded into the mesoporous glass without changing its amorphous structure and could be released over time. BG@Ber also showed good hemocompatibility and cytocompatibility in vitro. Compared with BG alone, BG@Ber showed a stronger regulatory effect on macrophage responses and further promoted osteogenic differentiation and mineralization in vitro. In a rat femoral condyle defect model, BG@Ber resulted in better bone formation and osseointegration with no obvious pathological abnormalities in major organs. Overall, berberine loading improved the biological performance of the mesoporous BG and was associated with better bone repair in vivo.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.